Richard Levy

Dr. Richard Levy has served on Protara’s board of directors since December 2019 and has more than 25 years of experience in the pharmaceutical and biotechnology industries. He is board certified in internal medicine and gastroenterology. Dr. Levy currently serves on the boards of directors of various biopharmaceutical companies, including Madrigal Pharmaceuticals, Inc., Kodiak Sciences, Inc. and Kiniksa Pharmaceuticals, Ltd. Additionally, Dr. Levy recently served as a part-time Senior Advisor for Baker Bros. Advisors, L.P. Prior to Dr. Levy’s board experience, he held an array of executive positions in the pharmaceutical industry, including in drug development, regulatory affairs and pharmacovigilance, clinical research, as well as medical and commercial strategy. Most recently, he served as Executive Vice President and Chief Drug Development Officer at Incyte from January 2009 until he retired in April 2016. His extensive industry experience includes positions at Celgene Corporation, DuPont Pharmaceuticals Company, Sandoz and Novartis. Dr. Levy holds a BA in Biology from Brown University and an MD from the University of Pennsylvania School of Medicine. He completed his training in internal medicine at the Hospital of the University of Pennsylvania and a fellowship in gastroenterology and hepatology at the University of California, Los Angeles.